Latest Institute for Research Stories
Company's collaborative partnership with IRICoR, Université de Montréal and MaRS Innovation, funded by Merck Canada, to advance macrocycle drug TORONTO and MONTREAL, Nov.
Chemists from the Institute of Research in Biomedicine (IRB) and from the R+D department of PharmaMar have devised a new synthesis method with pipecolidepsin A, a compound that is active against eleven types of cancers and property of PharmaMar.
Looking at the transformation of a fly larva into a pupa may help researchers to understand the molecular mechanisms that trigger puberty.
Cancer is characterized by uncontrolled cell division and growth.
- Growing in low tufty patches.